Keyphrases
Aptamer
100%
Sclerostin
95%
Bone Formation
81%
Osteoblastic
40%
Paclitaxel
40%
Osteoblast
33%
MicroRNA
29%
Nucleic Acids
27%
Programmed Death-ligand 1 (PD-L1)
27%
BMP Signaling
27%
Rheumatoid Arthritis
27%
Smad
27%
Breast Cancer Bone Metastasis
27%
Pancreatic Ductal Adenocarcinoma
27%
Pancreatic Cancer
27%
Drug Discovery
27%
Molecular Understanding
27%
Triple-negative Breast Cancer
27%
Therapeutic Strategies
23%
Breast Cancer
22%
Binding Affinity
21%
Osteoclast
21%
Therapeutic Target
21%
Osteogenesis Imperfecta
20%
Therapeutic Use
20%
In Cancer
20%
Breast Cancer Patients
19%
Tumor Progression
18%
Triple-negative Breast Cancer Cells
17%
Inflammation
17%
Tumor Cells
17%
Protective Behavior
17%
Nucleic Acid Aptamer
17%
Cardiovascular Risk
16%
Tumor Targeting
16%
Targeted Therapy
16%
Small Molecules
16%
Chemical Modification
16%
Inflammatory Response
15%
Mini
15%
Smurf1
15%
Wnt Signaling
15%
Aging
15%
Mouse Model
15%
Tumor
15%
Oligonucleotides
15%
Tumor Metastasis
14%
Chemotherapy
14%
ApoER2
14%
Sclerostin Inhibitor
14%
Hypoxia-inducible factor-1α (HIF-1α)
13%
Cell-SELEX
13%
Leflunomide
13%
Bone Erosion
13%
Antineoplastic Drugs
13%
Gain Cell
13%
PD-L1 Aptamers
13%
Ovarian Cancer
13%
Nucleolin Aptamer
13%
Osteolytic Metastasis
13%
MiR-214-3p
13%
Rare Bone Disease
13%
Therapeutic Perspectives
13%
Receptor Activator of nuclear factor-κB Ligand (RANKL)
13%
Lipopolymer
13%
Therapeutic Genome Editing
13%
Age-related Osteoporosis
13%
Phosphorus Metabolism
13%
Cardiovascular Protective
13%
PARP Inhibitor (PARPi)
13%
Aptamer Targeting
13%
Immune Checkpoint
13%
Shuttling Protein
13%
Nucleocytoplasmic Shuttling
13%
Carcinoma
13%
Vinorelbine
13%
Huaier Granule
13%
Immune System
13%
Systems-based
13%
Inflammatory Genes
13%
Water-soluble
13%
Vascular Endothelial Growth Factor
13%
MiRNA-mRNA Interaction
13%
Casein Kinase 2 Interacting protein-1 (CKIP-1)
13%
Structure Determination
13%
Joint Inflammation
13%
Extracellular Vesicles
13%
Gene Network
13%
Interleukin-17 (IL-17)
13%
Cancer Targeting
13%
Targeted Therapeutics
13%
Immune-related
13%
Molecular Therapeutics
13%
Single Center
13%
Targeting Strategies
13%
Cas9 Protein
13%
Inflammatory Process
13%
Vascular Endothelial
13%
Deep Learning Methods
13%
Glucocorticoid-induced Osteoporosis
13%
Pharmacology, Toxicology and Pharmaceutical Science
Aptamer
82%
Sclerostin
81%
Breast Cancer
42%
Neoplasm
41%
Drug Discovery
31%
Nucleic Acid
28%
Bone Metastasis
27%
Paclitaxel
27%
Malignant Neoplasm
25%
Osteogenesis Imperfecta
19%
microRNA
19%
Cardiovascular Risk
18%
Inflammation
17%
Metastasis
16%
Messenger RNA
15%
Bone Disease
15%
Monoclonal Antibody
15%
Tumor Growth
14%
Chemotherapy
14%
Retrospective Study
13%
Rheumatoid Arthritis
13%
Inflammatory Arthritis
13%
Bone Erosion
13%
Leflunomide
13%
Drug
13%
Nucleolin
13%
Triple Negative Breast Cancer
13%
microRNA 214
13%
Pancreas Cancer
13%
Programmed Death 1 Ligand 1
13%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
13%
Vinorelbine
13%
Carcinoma
13%
Tumor Necrosis Factor Receptor Associated Factor 3
13%
Ovary Cancer
13%
Vasculotropin A
13%
Osteoclast Differentiation Factor
13%
Lung Cancer
13%
Immunotherapy
13%
Osteosarcoma
13%
Diseases
9%
Apolipoprotein E Knockout Mouse
8%
Overall Survival
7%
Disease Free Survival
7%
Clinical Trial
6%
Immunogenicity
6%
Survival Rate
6%
Nanoparticle
6%
Lung Metastasis
5%
X-Linked Hypophosphatemia
5%
Mouse Model
5%
Receptor
5%
Nude Mouse
5%
Drug Delivery System
5%
Medicine and Dentistry
Aptamer
49%
Breast Cancer
40%
Ossification
29%
Bone Metastasis
27%
Sclerostin
27%
Osteoclast
20%
microRNA
19%
Targeted Therapy
17%
Cardiovascular System
17%
Tumor Cell
14%
Bone Morphogenetic Protein
13%
Metabolomics
13%
Tumor Necrosis Factor Receptor Associated Factor 3
13%
Osteoporosis
13%
Pancreas Adenocarcinoma
13%
Pancreas Cancer
13%
Drug
13%
Disorders of Calcium Metabolism
13%
Phosphate Metabolism
13%
Retrospective Study
13%
Proteomics
13%
Programmed Death-Ligand 1
13%
Triple Negative Breast Cancer
13%
Cancer Associated Fibroblast
13%
Osteoclast Differentiation Factor
13%
Vasculotropin A
13%
Clustered Regularly Interspaced Short Palindromic Repeat
13%
Chemokine
13%
microRNA 214
13%
Nucleic Acid
13%
Cas9
13%
Genome Editing
13%
Osteosarcoma
13%
Carcinoma
13%
Propensity Score Matching
13%
Paclitaxel
13%
Chondrocyte
13%
Osteoarthritis
13%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
13%
Alpha 1 Antitrypsin
13%
Tumor Microenvironment
11%
Neoplasm
10%
Diagnosis
10%
RNA Sequencing
8%
Biological Marker
8%
Hazard Ratio
7%
Disease Free Survival
7%
Overall Survival
7%
Monoclonal Antibody
7%
Cancer Cell
7%
Cancer
7%
Metastatic Carcinoma
7%
Cancer Therapy
6%
Receptor
6%
Fibroblast Growth Factor 23
6%
Parathyroid Hormone
6%
Isotopes of Calcium
6%
Survival Rate
6%
Spinal Fusion
5%
Chalcone Derivative
5%
Bone Morphogenetic Protein 2
5%
Cardiovascular System
5%
Lung Metastasis
5%
Angiogenesis
5%
Secretion (Process)
5%
Osteolysis
5%